Guardion Health Sciences, Inc. (NASDAQ:GHSI – Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 81,000 shares, a growth of 45.7% from the August 15th total of 55,600 shares. Based on an average daily trading volume, of 81,100 shares, the short-interest ratio is presently 1.0 days. Approximately 6.4% of the shares of the company are sold short.
Guardion Health Sciences Stock Performance
Shares of GHSI opened at $9.91 on Monday. Guardion Health Sciences has a fifty-two week low of $5.01 and a fifty-two week high of $18.00. The firm has a 50-day simple moving average of $10.57 and a 200-day simple moving average of $9.45. The company has a market capitalization of $12.72 million, a price-to-earnings ratio of -2.47 and a beta of 0.80.
Guardion Health Sciences (NASDAQ:GHSI – Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($1.64) EPS for the quarter. Guardion Health Sciences had a net margin of 22.79% and a negative return on equity of 73.69%. The company had revenue of $0.07 million for the quarter.
Guardion Health Sciences Dividend Announcement
About Guardion Health Sciences
Guardion Health Sciences, Inc, a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment.
Recommended Stories
- Five stocks we like better than Guardion Health Sciences
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Analysts See 51% Upside in Coinbase, Is It Time to Buy the Hype?
- What Are the FAANG Stocks and Are They Good Investments?
- NVIDIA May Send Chips to Saudi Arabia – Should You Sell the News?
- Ride Out The Recession With These Dividend Kings
- 3 Defensive Stock Alternatives to Bonds If Interest Rates Drop
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.